IBDEI39L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,54861,1,4,0)
 ;;=4^I50.33
 ;;^UTILITY(U,$J,358.3,54861,2)
 ;;=^5007246
 ;;^UTILITY(U,$J,358.3,54862,0)
 ;;=I50.40^^256^2773^9
 ;;^UTILITY(U,$J,358.3,54862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54862,1,3,0)
 ;;=3^Systolic & Diastolic Congestive Heart Failure,Combined Unspec
 ;;^UTILITY(U,$J,358.3,54862,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,54862,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,54863,0)
 ;;=I51.7^^256^2773^2
 ;;^UTILITY(U,$J,358.3,54863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54863,1,3,0)
 ;;=3^Cardiomegaly
 ;;^UTILITY(U,$J,358.3,54863,1,4,0)
 ;;=4^I51.7
 ;;^UTILITY(U,$J,358.3,54863,2)
 ;;=^5007257
 ;;^UTILITY(U,$J,358.3,54864,0)
 ;;=I42.6^^256^2773^1
 ;;^UTILITY(U,$J,358.3,54864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54864,1,3,0)
 ;;=3^Alcoholic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,54864,1,4,0)
 ;;=4^I42.6
 ;;^UTILITY(U,$J,358.3,54864,2)
 ;;=^5007197
 ;;^UTILITY(U,$J,358.3,54865,0)
 ;;=I50.1^^256^2773^8
 ;;^UTILITY(U,$J,358.3,54865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54865,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,54865,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,54865,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,54866,0)
 ;;=I50.20^^256^2773^13
 ;;^UTILITY(U,$J,358.3,54866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54866,1,3,0)
 ;;=3^Systolic Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,54866,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,54866,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,54867,0)
 ;;=I50.21^^256^2773^10
 ;;^UTILITY(U,$J,358.3,54867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54867,1,3,0)
 ;;=3^Systolic Heart Failure,Acute
 ;;^UTILITY(U,$J,358.3,54867,1,4,0)
 ;;=4^I50.21
 ;;^UTILITY(U,$J,358.3,54867,2)
 ;;=^5007240
 ;;^UTILITY(U,$J,358.3,54868,0)
 ;;=I50.22^^256^2773^12
 ;;^UTILITY(U,$J,358.3,54868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54868,1,3,0)
 ;;=3^Systolic Heart Failure,Chronic
 ;;^UTILITY(U,$J,358.3,54868,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,54868,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,54869,0)
 ;;=I50.23^^256^2773^11
 ;;^UTILITY(U,$J,358.3,54869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54869,1,3,0)
 ;;=3^Systolic Heart Failure,Acute on Chronic
 ;;^UTILITY(U,$J,358.3,54869,1,4,0)
 ;;=4^I50.23
 ;;^UTILITY(U,$J,358.3,54869,2)
 ;;=^5007242
 ;;^UTILITY(U,$J,358.3,54870,0)
 ;;=I50.30^^256^2773^6
 ;;^UTILITY(U,$J,358.3,54870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54870,1,3,0)
 ;;=3^Diastolic Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,54870,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,54870,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,54871,0)
 ;;=I50.9^^256^2773^7
 ;;^UTILITY(U,$J,358.3,54871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54871,1,3,0)
 ;;=3^Heart Failure,Unspec (CHF Unspec)
 ;;^UTILITY(U,$J,358.3,54871,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,54871,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,54872,0)
 ;;=I50.31^^256^2773^3
 ;;^UTILITY(U,$J,358.3,54872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54872,1,3,0)
 ;;=3^Diastolic Heart Failure,Acute
 ;;^UTILITY(U,$J,358.3,54872,1,4,0)
 ;;=4^I50.31
 ;;^UTILITY(U,$J,358.3,54872,2)
 ;;=^5007244
 ;;^UTILITY(U,$J,358.3,54873,0)
 ;;=I30.0^^256^2774^5
 ;;^UTILITY(U,$J,358.3,54873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54873,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,54873,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,54873,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,54874,0)
 ;;=I34.8^^256^2774^6
 ;;^UTILITY(U,$J,358.3,54874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54874,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
